Recombinant vaccinia virus vaccine (MUC-1) (Therion Biologics)

N/A

Report date: 2024/12/11 10:09:26

Base Information

Drug NameRecombinant vaccinia virus vaccine (MUC-1) (Therion Biologics)

Drug Alias NamerV-MUC-1rV-MUC-1

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTherion Biologics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTherion Biologics

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A